moxonidine has been researched along with Diabetic Angiopathies in 1 studies
moxonidine: structure given in first source
Diabetic Angiopathies: VASCULAR DISEASES that are associated with DIABETES MELLITUS.
Excerpt | Relevance | Reference |
---|---|---|
"Subjects with type 2 diabetes experience an increased cardiovascular morbidity and mortality, related to a high prevalence of hypertension, dyslipidemia, and obesity." | 2.71 | Effects of moxonidine vs. metoprolol on blood pressure and metabolic control in hypertensive subjects with type 2 diabetes. ( Gödicke, J; Häring, HU; Helsberg, K; Jacob, S; Klimm, HJ; Rett, K, 2004) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Jacob, S | 1 |
Klimm, HJ | 1 |
Rett, K | 1 |
Helsberg, K | 1 |
Häring, HU | 1 |
Gödicke, J | 1 |
1 trial available for moxonidine and Diabetic Angiopathies
Article | Year |
---|---|
Effects of moxonidine vs. metoprolol on blood pressure and metabolic control in hypertensive subjects with type 2 diabetes.
Topics: Adult; Aged; Antihypertensive Agents; Blood Pressure; Diabetes Mellitus, Type 2; Diabetic Angiopathi | 2004 |